Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakiba, Maryam, Nazemipour, Maryam, Salari, Arsalan, Mehrabian, Fardin, Nazari, Seyed Saeed H., Rezvani, Seyed Mahmoud, Ghasempour, Zahra, Heidarzadeh, Abtin, Mansournia, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853569/
https://www.ncbi.nlm.nih.gov/pubmed/33349310
http://dx.doi.org/10.3201/eid2702.201960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853569/
https://www.ncbi.nlm.nih.gov/pubmed/33349310
http://dx.doi.org/10.3201/eid2702.201960

Ejemplares similares